期刊文献+

动脉导管未闭介入封堵术后血小板减少的相关因素分析 被引量:15

Retrospective analysis of patients with thrombocytopenia after patent ductus arteriosus interventional occlusion
原文传递
导出
摘要 目的 探讨动脉导管未闭(PDA)患者介入封堵术后血小板减少的相关危险因素。方法回顾性分析350例接受PDA封堵治疗患者的临床资料,其中14例患者术后出现血小板减少症。记录患者的年龄、性别、体质量、PDA直径、封堵器直径、平均肺动脉压力、术中肝素用量、封堵器厂家和术后有无残余分流,并分析封堵术后血小板减少的独立危险因素。对患者术后血小板数量减少的程度进行分级,分析不同分级患者血小板计数恢复正常的时间。结果多因素logistic回归分析显示,封堵器直径(OR=2.238,P〈0.05)、术中肝素用量(OR:1.912,P〈0.05)、术后有无残余分流(OR=3.247,P〈0.01)是PDA封堵术后血小板减少的危险因素。对轻度血小板减少的患者不予临床干预,其血小板恢复时间为(7±2)d;对中度血小板减少的患者给予糖皮质激素治疗后,血小板恢复正常时间为(12±4)d;对重度血小板减少的患者输注血小板后,血小板恢复正常的时间为(21±7)d。结论封堵器直径、术中肝素用量、术后有无残余分流可能是导致PDA封堵术后血小板减少的危险因素。根据术后血小板减少程度的不同,通过临床观察及治疗,患者的血小板计数在不同时间内可恢复正常。 Objective To explore the risk factors of patent ductus arteriosus (PDA) patients with thrombocytopenia after PDA interventional occlusion. Methods Thrombocytopenia occurred in 14 out of 350 patients underwent PDA occlusion. Age, gender, body weight, PDA size, occluder size, mean pulmonary arterial pressure, the dose of heparin, the manufacturer of occlnder, residual shunt after operation were analyzed. The recovery time of different grades of thrombocytopenia was observed. Results Multivariate logistic regression showed that the PDA size ( OR = 2. 238, P 〈 0. 05 ), the dose of heparin ( OR = 3. 247,P 〈 0. 05 ) , residual shunt after operation ( OR = 1.912, P 〈 0. 01 ) were the independent risk factors of thromhocytopenia after PDA occlusion. The recovery time of mild thrombocytopenia was ( 7 ± 2 ) days without treatment. The recovery time of moderate thrombocytopenia was (12± 4 ) days with glucocortieoids treatment. The recovery time of severe thrombocytopenia was (21 ± 7 ) days with platelet transfusion. Conclusions The oeeluder size, dose of heparin, residual shunt are the independent risk factors of thromboeytopenia after PDA interventional occlusion. Recover time of thrombocytopenia after PDA interventional occlusion is closely related to the severity of thrombocytopenia.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2013年第3期229-232,共4页 Chinese Journal of Cardiology
关键词 动脉导管未闭 心脏导管插入术 血小板减少 Ductus arteriosus, patent Heart catheterization Thrombocytopenia
  • 相关文献

参考文献13

  • 1解启莲,张密林,王震.动脉导管未闭患儿介入封堵术后并发血小板减少症三例[J].中华医学杂志,2005,85(36):2532-2532. 被引量:13
  • 2于连慧,刘和平,孟繁超,王玉库.动脉导管未闭经导管封堵术后血小板减少三例(附3例报告及文献复习)[J].中国心血管病研究,2008,6(3):163-164. 被引量:11
  • 3梁静,周玉杰,史冬梅,马涵英,刘宇扬.动脉导管未闭封堵术后血小板减少一例[J].中国介入心脏病学杂志,2008,16(5):287-287. 被引量:21
  • 4卢竞前,吕云,李易.与动脉导管未闭介入封堵相关的血小板减少症三例临床分析[J].中国介入心脏病学杂志,2010,18(5):299-300. 被引量:12
  • 5Hui P, Cook D J, Lim W, et al. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest, 2011,139:271-278.
  • 6Warkentin TE, Greinacher A, Koster A, et al. Treatment and prevention of heparin-induced thromboeytopenia : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133:340S-380S.
  • 7Liukins LA, Darts AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012,141 : e495S-e530S.
  • 8Cohen RA, Castellano M, Garcia CA. Heparin induced thrombocytopenia: case presentation and review. J Clin Med Res, 2012, 4:68-72.
  • 9Webert K, Cook R J, Sigouin CS, et al. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica, 2006,91 : 1530-1537.
  • 10Kim H, Lee JH, Choi SJ, et al. Risk score model for fatal intracranial hemorrhage in acute leukemia. Leukemia, 2006, 20: 770-776.

二级参考文献22

  • 1解启莲,张密林,王震.动脉导管未闭患儿介入封堵术后并发血小板减少症三例[J].中华医学杂志,2005,85(36):2532-2532. 被引量:13
  • 2Linda Shore-Lesserson. New anticoagulants agents. Can J Anesth, 2004. 51 : R9.
  • 3Warkentin TE. Heparln induced thromboeytopenia: a ten-year retrospective. Annu Rev Med,1999, 50: 129-147.
  • 4Ismail Elalamy. Heparin-induced thrombocytopenia: Laboratory diagnosis and management. The finnish medical society duodecim. Ann Med ,2000,32:60-67.
  • 5Lindhoff-Last E, Gerdsen F, Ackennann H, el al. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia. Br J Haemacol, 2001,113 : 886-890.
  • 6[2]Bermudz CR,Santotoro G,Bialkowsky J,et al.Patent ductus arteriosus occlusion using detachable coils.Am J Cardiol,1998,82:1547.
  • 7[3]Tomita H,Fuse S,Akagi T,et al.Hemolysis complicating coil occulusion of patent ductus arteriosus.Cathet Cardiovasc Dingn,1998,43:50.
  • 8Elalamy I,Lecrubier C,Horellou MH,et al.Heparin-induced thrombocytopenia:laboratory diagnosis and management.Ann Med,2000,32:60-67.
  • 9Butera G, De Rosa G, Chessa M, et al. Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children [J]. Heart, 2004, 90: 1467 - 1470.
  • 10Pass RH, Hijazi Z, Hsu DT, et al. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one- year results[J]. J Am Coll Cardiol, 2004, 44:513 - 519.

共引文献124

同被引文献95

引证文献15

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部